Synapse

← Cancer Treatment and Research Communications

Papers in Cancer Treatment and Research Communications

Page 3 · newest first

  1. Biomarker analyses to predict benefit of immune checkpoint inhibitors for EGFR-mutated non-small cell lung cancerCancer Treatment and Research Communications · 2026
  2. Cancer treatment-related risk factors for stroke among patients with lung cancer: A systematic review and meta-analysisCancer Treatment and Research Communications · 2026
  3. A Pan-Cancer Portrait of PDK1: From Oncogenic Driver to Context-Dependent Immunological RegulatorCancer Treatment and Research Communications · 2026
  4. The Evolving Role of Physiotherapy in Oncology Rehabilitation: An Evidence-Based Review Addressing Scope, Efficacy, Equity, and Educational ImperativesCancer Treatment and Research Communications · 2026
  5. Systematic literature review of secondary primary malignancies related to a CAR-T treatment in patients with multiple myeloma, lymphoma or leukemiaCancer Treatment and Research Communications · 2026
  6. Non-Coding RNAs at the Intersection of Interferon Signaling and Cancer: Mechanistic Insights and Clinical ProspectsCancer Treatment and Research Communications · 2026
  7. Assessment of Bacterial Infection Risk Factors and Related Complications in Newly Diagnosed Multiple Myeloma: A Retrospective Cohort AnalysisCancer Treatment and Research Communications · 2026
  8. Assessing the Correlation Between CD15 Expression and Gleason Score and Grade Groups in Prostate Adenocarcinoma: A Cross-Sectional StudyCancer Treatment and Research Communications · 2026
  9. Preliminary evaluation of Chidamide in combination with novel [177Lu]Lu-DOTAGA-Rituximab in Rituximab-resistant Raji cellsCancer Treatment and Research Communications · 2026
  10. HDAC4 overexpression predicts aggressive phenotypes and poor outcomes in urothelial carcinomaCancer Treatment and Research Communications · 2026
  11. Reference materials and External Quality Assessment for Liquid Biopsy assays: Expert Opinions from the European Liquid Biopsy Society ctDNA WorkshopCancer Treatment and Research Communications · 2026
  12. Emerging Light-Based Strategies in Cancer Theranostics: Photodynamic Therapy, Nanomedicine, and Precision OncologyCancer Treatment and Research Communications · 2026
  13. Durable Clinical Benefit and Progression-Free Survival in Patients with PD-L1 ≥50% NSCLC Receiving Pembrolizumab: Impact of Nutritional and Inflammatory MarkersCancer Treatment and Research Communications · 2026
  14. Exploring Knowledge, Attitudes, and Practices on Cervical Cancer Screening and Their Associated Factors among Female University Students at Debre Markos University, EthiopiaCancer Treatment and Research Communications · 2026
  15. Metabolic Signatures and Predictive Biomarkers of Liposomal Doxorubicin-Induced Hypersensitivity in Breast Cancer: A Pilot StudyCancer Treatment and Research Communications · 2026
  16. Precision oncology in Bulgaria: a prospective study of metastatic colorectal cancer patientsCancer Treatment and Research Communications · 2026
  17. Artificial intelligence in oral oncology: Current advances and future potential in diagnosis, prognosis, and therapeutic decision-makingCancer Treatment and Research Communications · 2026
  18. Microvessel density as a prognostic factor in renal cell carcinoma: A systematic review and meta-analysis with individual patient data reconstructed from previous Kaplan‒Meier curvesCancer Treatment and Research Communications · 2026
  19. A predictive nomogram for cancer-specific survival in elderly patients with ductal carcinoma in situ after lumpectomy: A SEER-based retrospective studyCancer Treatment and Research Communications · 2026
  20. BRAF mutation predicts survival after immunotherapy across multiple cancer typesCancer Treatment and Research Communications · 2026
  21. Treatment of ER-positive breast cancer with FDA-approved aromatase inhibitorsCancer Treatment and Research Communications · 2026
  22. An attention-guided residual 3D U-net with focal Tversky–Dice loss for multi-modal pancreatic tumor segmentation using synthetic volumetric imagingCancer Treatment and Research Communications · 2026
  23. The association between parity, age of first full term pregnancy and invasive lobular breast cancer: a case-only analysisCancer Treatment and Research Communications · 2026
  24. Knowledge, attitude, and practice of healthcare professionals towards the prevention of Marjolin’s ulcer in an African suburban tertiary care institution: A cross-sectional studyCancer Treatment and Research Communications · 2026
  25. Treatment landscape, outcomes, and healthcare resource utilization in FLT3+ relapsed/refractory acute myeloid leukemia in MexicoCancer Treatment and Research Communications · 2026
  26. RHOXF1/TSGA10 axis: a possible molecular mechanism of carcinogenesisCancer Treatment and Research Communications · 2026
  27. Multimodal liquid biopsy surveillance after pancreatectomy for pancreatic ductal adenocarcinoma: evidence and a confirmation‑gated, trial‑ready frameworkCancer Treatment and Research Communications · 2026
  28. Integrative multi-omics and machine learning/deep learning approaches in cancer knowledge discovery: A scoping reviewCancer Treatment and Research Communications · 2026
  29. Synergistic cytotoxic effect of doxorubicin and bortezomib on lung cancer cell lines using 2D and 3D modelsCancer Treatment and Research Communications · 2026
  30. Malaria driven mechanisms shaping cancer risk and aggressiveness in African populationsCancer Treatment and Research Communications · 2026
  31. Transcriptomic landscape of coexisting ovarian clear cell carcinoma and endometriosis: Insights into malignant transformationCancer Treatment and Research Communications · 2026
  32. Colorectal cancer trends in Iran: An age-period-cohort analysis of incidence and mortality and trends in key risk factorsCancer Treatment and Research Communications · 2026
  33. Chemotherapy-induced liver injury in Tibetan breast cancer patients: clinical features and risk factor analysisCancer Treatment and Research Communications · 2026
  34. Clinical characteristics and survival outcomes of young women with luminal HER2-low and HER2-ultralow breast cancerCancer Treatment and Research Communications · 2026
  35. Development and pilot feasibility of Kit-CAT, a serious-game-supported consultation for discussing complementary and alternative therapies in breast cancer careCancer Treatment and Research Communications · 2026
  36. Harnessing tumor-agnostic biomarkers for precision medicine in lymphomaCancer Treatment and Research Communications · 2026
  37. Survival outcomes in EGFR-mutant versus wild-type locally advanced non-small cell lung cancer treated with definitive chemoradiotherapy alone in the pre-PACIFIC/LAURA trial era: A systematic review and meta-analysis using reconstructed individual patient dataCancer Treatment and Research Communications · 2026
  38. Clinical significance of immunocyte- and ferroptosis-related markers for the prognosis of patients with tenosynovial giant cell tumor: A cross-sectional studyCancer Treatment and Research Communications · 2026
  39. Cholesteryl ester and cholesterol as candidate biomarkers for differentiating primary lung squamous cell carcinoma from head and neck squamous cell carcinoma; proof-of-concept biomarker studyCancer Treatment and Research Communications · 2026
  40. Dual-jet transition cold atmospheric plasma suppresses colon cancer stem cells via matrix metalloproteinase regulationCancer Treatment and Research Communications · 2026
  41. The microbiome–epigenome axis: Regulation of host genome function across development and diseaseCancer Treatment and Research Communications · 2026
  42. Immune Checkpoint Inhibitor Outcomes Across Child-Pugh A, B, and C Hepatocellular Carcinoma: A Real-World Integrated Health-System CohortCancer Treatment and Research Communications · 2026
  43. Assessment of national cancer care network guideline-adherent treatment differences as a contributor to racial disparities in epithelial and non-epithelial ovarian cancer survivalCancer Treatment and Research Communications · 2026
  44. Immunogenic effects of hyperthermia in an experimental model of peritoneal metastases of colorectal cancer enhance tumor susceptibility to immunotherapyCancer Treatment and Research Communications · 2026
  45. Second primary malignancies after stereotactic body radiotherapy vs surgery for early-stage lung cancer: a U.S. population-based study, 2010-2015Cancer Treatment and Research Communications · 2026
  46. Tolvaptan for paraneoplastic SIADH in small cell lung cancer: a scoping reviewCancer Treatment and Research Communications · 2026
  47. Prevalence of cancer-related fatigue after treatment in patients with non-metastatic gastrointestinal cancersCancer Treatment and Research Communications · 2026
  48. Lenvatinib plus pembrolizumab for advanced or recurrent endometrial cancer: a retrospective multi-institutional survey in the Kinki district of JapanCancer Treatment and Research Communications · 2026
  49. Natural and in vitro-generated regulatory T-cell subsets differentially modulate phenotype and drug response in K562 leukemic cellsCancer Treatment and Research Communications · 2026
  50. The eco-evolutionary dynamics of acute myeloid leukemia: From clonal games to clinical interventionCancer Treatment and Research Communications · 2026